安捷伦科技(NYSE:A)股价持续攀升:强劲财务表现引领市场走势?- 雅虎财经
Agilent Technologies, Inc.'s (NYSE:A) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - Yahoo Finance
生物技术与制药领域的最新动态
Agilent Technologies, Inc.'s (NYSE:A) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - Yahoo Finance
Vaxcyte strikes up to $1B deal for fill-finish space at Thermo Fisher's N.C. production facility - Fierce Pharma
Centre for Alternate Protein Research launched at University of Hyderabad’s Aspire-BioNest - theplantbasemag.com
Why Is Illumina (ILMN) Stock Rocketing Higher Today - Yahoo Finance
Illumina launches AI informatics business for multi-omic drug discovery - Fierce Biotech
Illumina launches new business to accelerate technology and data-driven discovery - PR Newswire
Waters Corporation Schedules Third Quarter 2025 Earnings Conference Call - Yahoo Finance
Agilent Technologies, Inc. (A) Partners With AI Firm Lunit to Advance Cancer Diagnostics - Yahoo Finance
Thermo Fisher Scientific Announces R&D Partnership with AstraZeneca BioVentureHub - Business Wire
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 22, 2025 - Business Wire
Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes - Business Wire
Thermo Fisher Scientific Showcases the Thermo Fisher Connect Platform at Lab of the Future Europe - Business Wire
Agrigenomics arrays and consortia | Collaborating with experts - Illumina
Comparative analysis of illumina and oxford nanopore sequencing platforms for 16S rRNA profiling of respiratory microbial communities | Scientific Reports - Nature
Lonza’s Synaffix Collaborates with Qurient Therapeutics on Dual-Payload ADC Development - GEN - Genetic Engineering and Biotechnology News
Lonza’s Synaffix and Qurient team up on dual-payload ADC - The Pharma Letter
RION engages Lonza to scale manufacturing exosome based therapeutics - News-Medical
Roche, Novartis underline U.S. plans after Trump pharma tariff announcement - Reuters
Leveraging illumina iSeq100 for whole genome sequencing of Salmonella Typhi for a resource-limited setting - Nature
Lonza's Synaffix Collaborates with Qurient Therapeutics to Enable Development of Dual-Payload ADC - Yahoo Finance